Amanote Research
Register
Sign In
Willingness of Patients With Ankylosing Spondylitis to Pay for Inpatient Treatment Is Influenced by the Treatment Environment and Expectations of Improvement
Annals of the Rheumatic Diseases
- United Kingdom
doi 10.1136/ard.2005.038786
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Date
August 26, 2005
Authors
A Boonen
Publisher
BMJ
Related search
Straightening Out Treatment Recommendations for Ankylosing Spondylitis
Pharmacy Today
Microvascular Dysfunction in Ankylosing Spondylitis Is Associated With Disease Activity and Is Improved by Anti-TNF Treatment
Scientific Reports
Multidisciplinary
TNF-alpha Antagonists for Treatment of Juvenile Ankylosing Spondylitis
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
The Treatment of Spinal Pseudarthrosis in Ankylosing Spondylitis
Journal of the Korean Orthopaedic Association
The Association ofNLRP3andTNFRSF1Apolymorphisms With Risk of Ankylosing Spondylitis and Treatment Efficacy of Etanercept
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
LINC00311 Is Overexpressed in Ankylosing Spondylitis and Predict Treatment Outcomes and Recurrence
BMC Musculoskeletal Disorders
Rheumatology
Orthopedics
Sports Medicine
Ankylosing Spondylitis: Patterns of Spinal Injury and Treatment Outcomes
Asian Spine Journal
Surgery
Orthopedics
Sports Medicine
Is the Health Utilities Index 3 Valid for Patients With Ankylosing Spondylitis?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Celecoxib Versus Diclofenac for the Treatment of Ankylosing Spondylitis: 12-Week Randomized Study in Norwegian Patients
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
